DKFZ Deutsche Krebsforschungszentrum is a German private company that operates as a cancer research center.

OncoHealth Corp. operates as a protein biomarker diagnostics company. It commercializes unique proprietary tests for cervical cancer and other cancers associated with human papillomavirus (HPV). The company was founded by Winnie H. Wan and Shuling Cheng in December on July 26, 2010 and is headquartered in Mountain View, CA.

PANAGENE Inc. engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips. The firm operates through the PNA Materials and Diagnostic Product business divisions. Its products are marketed as PANAMutyper, PNAClamp, PANArray, PANA qPCR, PNA Oligo and Monomer. The company was founded on April 16, 2001 and is headquartered in Daejeon, South Korea.

New Horizon Health is an innovative bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes. Nuohui Health is committed to reducing the morbidity and mortality of cancer through biotechnological means. It first proposed the slogan of early cancer screening and is committed to promoting early cancer screening into thousands of households so that the public can enjoy convenient and efficient health services .

Oxford University Innovation is the University of Oxford's technology transfer company and manages the University's intellectual property portfolio, working with University researchers on identifying, protecting and marketing technologies through licensing, spin-out company formation and material sales. Oxford University Innovation also manages Oxford University Consulting, which arranges consulting services providing clients access to the expertise of the University's academics. Oxford University’s overarching Strategic Plan begins, “The University of Oxford aims to lead the world in research and education” immediately followed by, “They seek to do this in ways which benefit society on a national and a global scale.” Oxford University Innovation helps staff and students to apply their expertise and research for wider social and economic benefit. Their role is to help University staff and students bring the benefits of their research and expertise to create impact in wider society. They support Oxford’s researchers, staff and students, offering commercial skills and a range of specialist resources in order to maximise research impact. Income is shared with those involved according to the University’s Regulations.

Wuhan Heer Medical Technology Development Co. Ltd., a subsidiary of Boai NKY Medical Holdings Ltd., is a company headquartered in Wuhan, China, that engages in medical equipment development operation. It was acquired by Boai NKY Medical Holdings Ltd. on November 13, 2014 for $46.72 million.

M&D specializes in the power plant and industrial facility diagnostic equipment development services.

My gene conducts genetic research by using a saliva DNA test that decodes genetic code & instructs how to apply genetic analysis every day.

QuantaMatrix, Inc. provides optical devices for microbiological and molecular diagnostics. Its products include QMAC and QMAP. The company was founded by Sung-Hoon Kwon on November 29, 2010 and is headquartered in Seoul, South Korea.

DiagCor Bioscience, Inc. Ltd. develops and commercializes in vitro diagnostic kits and instruments. It offers a complete platform for commercial and clinical MDx diagnosis. The firm serves clinical diagnostic services markets in Latin America, Europe, Middle East and South East Asia. Its products include R2-M flow-through hybridization system, FT-PRO flow-through hybridization system, capture-PRO image capture system, Taigen VacEZor and FT-PRO auto system. The company was founded by Joseph Wing On Tam in 2006 and is headquartered in Hong Kong.

Optipharm provides a biomedical solution that is involved in the development of cell therapy products using animal stem cells. The company was founded in July 2000 as Avicore Biotechnology Research Center and merged with Medipig Korea and Optipharm Solution Center in December 2007, after which it was renamed Optipharm Solution. It entered the veterinary medicine field in April 2008 by acquiring Farmscare, and it was listed on the KOSDAQ in October 2018 after the company's name was changed to its current name Optipharm in September 2012. It is currently involved in the business of animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, and so on, and it is expanding into the field of human medicine based on the technology that it has accumulated in the field of animal medicine.

Genetel Pharmaceuticals Shenzhen Co. Ltd., a subsidiary of Mingyuan Medicare Development Co. Ltd., is a company headquartered in Shenzhen, China. The firm manufactures and sells pharmaceuticals and medical instruments.

HEAS BioTech provides biological sample processing, molecular pathology, and POCT services. HEAS BioTech has built an R&D center of 1,400 square meters, a GMP standard production plant of 2,200 square meters, and a production system for medical reagents and equipment.

BGI Shenzhen Co., Ltd. engages in the equity investment and asset management. Its business scope includes research and development and sales of computer hardware and software and peripheral equipment technology; import and export of goods and technology; equity investment; investment in industrial development; and aquatic product farming and sales. The company was founded on August 21, 2008 and is headquartered in Shenzhen, China.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Shanghai Xingyao Medical Technology Development Co., Ltd. engages in the research and development, production, marketing, sale, and service of in vitro diagnostic reagents and equipment. The company was founded on May 30, 1994 and is headquartered in Shanghai, China.

Jiangsu Mole Biotechnology Co., Ltd., established on 2008-05-29, The scope of business includes the development of biotechnology,consult,Promotion and Transfer Services,Production and sales of medical devices,production of medicines,Medical equipment rental service,Medical laboratory diagnosis and treatment,Medical Software Development Services,Invest in the medical industry with your own funds;Self-operated and agent import and export business of various domestic commodities and technologies(Except for commodities and technologies that are prohibited or restricted by the state).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)